专题:Cutaneous lymphoproliferative disorders research

This cluster of papers focuses on the classification, staging, treatment, and prognosis of cutaneous lymphomas, with a specific emphasis on mycosis fungoides and Sézary syndrome. It includes discussions on the WHO-EORTC classification, survival outcomes, prognostic factors, and various treatment options such as bexarotene and denileukin diftitox. The cluster also addresses the incidence patterns, genomic landscape, and molecular profiling of cutaneous T-cell lymphomas.
最新文献
Pruritic Plaque on the Right Lower Limb: A Rare Case of Kimura Disease and Literature Review

article Full Text OpenAlex

Association between Ki-67 and clinical outcomes in 324 Chinese patients with resectable acral melanoma

article Full Text OpenAlex

Primary Cutaneous CD4+ Small/Medium-Sized T-Cell Lymphoproliferative Disorder: A Retrospective Cohort Study of 40 Adult Patients

article Full Text OpenAlex

Camidanlumab Tesirine for Relapsed or Refractory Classic Hodgkin Lymphoma: A Phase 2 Study

article Full Text OpenAlex

Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA

article Full Text OpenAlex

Dermatopathology Trainee World Cup Abstract Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA

article Full Text OpenAlex

[Sudden onset of erythematous papules on the upper limbs and trunk].

article Full Text OpenAlex

Anti-Mi2 autoantibodies target PHD fingers of SP140L and TIF1γ, while anti-TIF1γ autoantibodies primarily bind TIF1γ outside the PHD region

article Full Text OpenAlex

Primary Soft Tissue DLBCL Mimicking Sarcoma

article Full Text OpenAlex

Farber's Lipogranulomatosis: Multimodal Therapy With Tocilizumab and Consolidative HSCT Improves Assessment, and Long‐Term Outcome

article Full Text OpenAlex

近5年高被引文献
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

article Full Text OpenAlex 597 FWCI77.745

CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up

article Full Text OpenAlex 482 FWCI215.852

Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

article Full Text OpenAlex 458 FWCI63.843

The incidence and clinical analysis of non-melanoma skin cancer

article Full Text OpenAlex 216 FWCI32.149

CAR T-cell therapy in autoimmune diseases

review Full Text OpenAlex 213 FWCI15.085

The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma

article Full Text OpenAlex 203 FWCI26.699

Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches

review Full Text OpenAlex 190 FWCI7.129

Mycosis Fungoides and Sézary Syndrome

article Full Text OpenAlex 177 FWCI0.47

Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma

article Full Text OpenAlex 175 FWCI33.819

Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial

article Full Text OpenAlex 156 FWCI72.215